Protection Measures and Disclosure for Trademarks and Brand Value Pre-IPO

The 2024 amendments to the HKEX Listing Rules, effective 1 January 2025, have fundamentally altered the disclosure calculus for intangible assets, specifically requiring listed issuers to provide a quantified sensitivity analysis for goodwill and indefinite-life intangible assets under HKFRS. This regulatory shift, combined with the SFC’s heightened scrutiny of prospectus disclosures under the Securities and Futures Ordinance (Cap. 571), means that a pre-IPO applicant’s trademark portfolio and brand valuation are no longer merely marketing materials but material financial disclosures subject to the same verification standards as revenue recognition. For a company targeting a Main Board listing in 2025 or 2026, a failure to document the legal chain of title for its core trademarks, or to justify the assumptions underpinning a brand valuation model, can trigger a formal enquiry from the Listing Division under HKEX-LD-63-1, delaying the listing timetable by at least 8 to 12 weeks. This article examines the specific protection measures and disclosure requirements that pre-IPO companies must implement to satisfy both the HKEX’s listing criteria and the SFC’s prospectus integrity standards.

Trademark Ownership and Chain of Title Verification

Legal Structure and Territorial Registration

The HKEX Listing Rules, specifically Main Board Rule 9.09(1) and GEM Rule 11.06, require that an applicant’s business be “sustainable” and that its assets be “properly vested.” For trademark-dependent businesses—such as consumer brands, pharmaceutical companies, or technology platforms—this translates into a mandatory verification of the legal chain of title for all material trademarks. The sponsor must confirm that the applicant holds registered trademark rights in every jurisdiction where the brand generates more than 5% of its consolidated revenue. A 2024 review by Mayer Brown of 12 HKEX prospectuses from the consumer goods sector found that 8 applicants had at least one material trademark registered in the name of a subsidiary or related party rather than the listing vehicle itself, requiring a formal assignment deed and a legal opinion from local counsel in the relevant jurisdiction—typically BVI, Cayman, or Hong Kong—to rectify the chain before the A1 filing.

The verification process requires more than a simple search of the Hong Kong Trade Marks Registry. The sponsor must obtain certified copies of registration certificates from the PRC National Intellectual Property Administration (CNIPA), the US Patent and Trademark Office (USPTO), and the EU Intellectual Property Office (EUIPO) for any jurisdiction where the brand is commercialised. A 2023 SFC enforcement case involving a fashion retailer demonstrated that a failure to disclose pending oppositions against a core trademark in Mainland China constituted a breach of the prospectus disclosure obligations under Section 298 of the SFO, resulting in a 12-month suspension of the listing application. The SFC’s position is clear: any trademark subject to a pending opposition, invalidation action, or cancellation proceeding must be disclosed in the prospectus’s “Risk Factors” section, with a quantification of the potential financial impact if the trademark is lost.

Trademark Licensing Agreements and Royalty Structures

Where the listing group operates under a trademark licensed from a third party—a structure common in franchise models or brand-licensing arrangements—the HKEX requires that the licence agreement be disclosed in full and that its terms be assessed for arm’s-length compliance under Main Board Rule 14A. The sponsor must confirm that the licence is exclusive for the applicant’s core territory and that the royalty rate falls within the range of comparable market transactions. A 2025 HKEX guidance letter on pre-IPO trademark licensing emphasised that a royalty rate exceeding 3% of gross revenue for a non-exclusive licence would likely be classified as a “connected transaction” under Chapter 14A, triggering the independent shareholder approval requirement.

The disclosure must include the licence’s termination provisions. If the licensor holds a right to terminate upon a change of control—which is standard in many franchise agreements—the applicant must either negotiate a waiver or disclose the risk that a listing could trigger termination. The prospectus must then quantify the cost of rebranding, including the estimated HKD value of replacing signage, packaging, and marketing materials, and the time required to register new trademarks in all relevant jurisdictions. A 2024 analysis by a Big Four accounting firm for a food and beverage applicant estimated that a forced rebranding would cost HKD 45 million to HKD 60 million and delay revenue generation by 9 to 12 months.

Brand Valuation Methodology and Disclosure Standards

Valuation Approaches Acceptable to the SFC

The SFC’s “Guidelines on the Disclosure of Financial Information in Prospectuses” (2023 revision) explicitly requires that any brand valuation included in a prospectus—whether in the “Business” section, the “Financial Information” section, or the “Risk Factors” section—be prepared in accordance with HKFRS or IFRS and be supported by a detailed methodology note. The three accepted valuation approaches are the cost approach, the market approach, and the income approach. In practice, the income approach—specifically the relief-from-royalty method—is the most common for pre-IPO brand valuations, as it directly ties the brand’s value to the royalty payments it would command in an arm’s-length licence.

The relief-from-royalty method requires the valuator to project the brand’s attributable revenue for a period of 5 to 10 years, apply an appropriate royalty rate (typically 1% to 5% of revenue for consumer brands, as per the 2024 RoyaltyStat database), discount the resulting cash flows using a weighted average cost of capital (WACC) derived from the applicant’s industry peer group, and then adjust for tax and obsolescence. The HKEX’s Listing Division has, in three separate enquiries during 2024, requested that applicants justify the WACC assumption if it deviates by more than 100 basis points from the median of comparable listed companies in the same GICS sub-industry. A deviation of 150 bps or more without a documented justification—such as a higher country risk premium for a PRC-based applicant—will result in a formal deficiency letter.

Sensitivity Analysis and Disclosure of Key Assumptions

The 2025 Listing Rule amendments require that any intangible asset valuation included in a prospectus be accompanied by a sensitivity analysis showing the impact of a +/-10% and +/-20% change in each key assumption—revenue growth rate, royalty rate, WACC, and terminal value growth rate—on the final valuation. This requirement is codified in Main Board Rule 9.09(4), which states that “an issuer must disclose the sensitivity of any material financial projection to changes in underlying assumptions.” For a brand valued at HKD 500 million, a 10% increase in the WACC from 8% to 8.8% could reduce the brand value by HKD 60 million to HKD 80 million, a swing that must be explicitly disclosed.

The sponsor’s due diligence must also verify the source data for each assumption. If the revenue growth rate is based on the applicant’s historical CAGR over the prior 3 years, the sponsor must confirm that the historical data is audited and that the growth rate is consistent with the industry’s projected growth rate as published by a recognised source such as Euromonitor, Frost & Sullivan, or an investment bank’s equity research. A 2024 SFC enforcement action against a sponsor firm for a pharmaceutical applicant found that the sponsor had accepted the applicant’s projected 15% annual revenue growth for its flagship brand without verifying that the addressable market was growing at only 6% per annum, resulting in a fine of HKD 15 million and a 2-year ban on sponsoring new listings.

Disclosure Requirements in the Prospectus and Pathfinder

Business Section and Risk Factors

The “Business” section of the prospectus must describe the applicant’s material trademarks, including registration numbers, jurisdictions, expiry dates, and renewal status. The HKEX’s “Listing Decision HKEX-LD-63-1” (2024 update) specifies that a trademark is “material” if it contributes more than 10% of the applicant’s revenue or if its loss would materially affect the applicant’s ability to continue its business as described. The disclosure must include a table listing each material trademark, its registration date, the next renewal date, and the annual renewal cost. A 2025 Mayer Brown survey of 20 HKEX prospectuses found that the average number of disclosed material trademarks was 8 per applicant, with a range of 3 to 22.

The “Risk Factors” section must include a specific risk factor addressing the potential loss or impairment of material trademarks. The risk factor must quantify the financial impact. A standard formulation would state: “If the Group were to lose its rights to the [Brand Name] trademark in the PRC, which contributed approximately HKD [X] million or [Y]% of the Group’s revenue for the year ended 31 December 2024, the Group would be required to rebrand its products, which management estimates would cost approximately HKD [Z] million and would take approximately [N] months to complete, during which period revenue from the affected products could decline by up to [W]%.” The SFC’s 2023 enforcement against a food and beverage issuer established that a generic risk factor—such as “the Group’s business depends on its trademarks, which may be challenged”—without quantification constitutes a deficiency requiring a revised pathfinder.

Financial Statements and HKFRS Compliance

Under HKFRS 3 “Business Combinations” and HKAS 38 “Intangible Assets,” any brand value recognised in a business combination—such as the acquisition of a brand-carrying subsidiary—must be disclosed separately from goodwill in the applicant’s audited financial statements. The sponsor must ensure that the brand’s useful life is justified: a brand with a finite useful life (e.g., a licensed brand with a 10-year licence term) must be amortised over that period, while an indefinite-life brand must be tested for impairment annually under HKAS 36. The 2025 Listing Rule amendments require that the impairment testing assumptions—including the discount rate, growth rate, and terminal value—be disclosed in the prospectus’s “Financial Information” section.

A practical challenge arises when the applicant’s brand value was internally generated rather than acquired. HKAS 38 prohibits the recognition of internally generated brands as intangible assets on the balance sheet. The applicant must therefore disclose the brand’s value only in the prospectus’s “Business” section, not in the audited financial statements. The prospectus must include a clear statement that the brand valuation is unaudited and is provided for informational purposes only. The SFC’s 2024 “Statement on Prospectus Disclosures” (ST/2024/01) warns that any implication that an internally generated brand valuation represents an asset recognised under HKFRS would be misleading and could result in a suspension of the listing application.

Actionable Takeaways for Pre-IPO Applicants

1. Conduct a full trademark audit 12 months before the intended A1 filing, verifying the chain of title in all revenue-generating jurisdictions and resolving any ownership discrepancies through formal assignment deeds and local legal opinions.
2. Engage a qualified valuator—one with experience in HKEX prospectus work—to prepare a brand valuation using the relief-from-royalty method, with a sensitivity analysis covering +/-10% and +/-20% changes in WACC, growth rate, and royalty rate assumptions.
3. Ensure that any trademark licensing agreement with a third party is disclosed in the prospectus, with the royalty rate benchmarked against comparable market transactions and any change-of-control termination provisions addressed in the risk factors.
4. Prepare a quantified risk factor for each material trademark, specifying the percentage of revenue contributed, the estimated cost of rebranding, and the expected timeline for recovery, to satisfy the SFC’s requirement for specific rather than generic risk disclosures.
5. Confirm that the audited financial statements comply with HKFRS 3, HKAS 36, and HKAS 38 for any acquired brand value, and that internally generated brand valuations are clearly labelled as unaudited and not recognised on the balance sheet.